logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

AmirAli Talasaz

This inventor holds 19 USPTO granted patents and 9 published patent applications and 16 EPO patents, primarily in Genetic Diagnostics. Top assignees: Guardant Health, Inc., Illumina Corporation, Guardant Helath, Inc.. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: AmirAli Talasaz. Retrieved from https://idiyas.com/inventor/amirali-talasaz-4omb1zdn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.7

ph-index = 11

Forward Citations = 901(Granted Patents)


Location History:

  • Redwood City, CA (US) (2020)
  • Menlo Park, CA (US) (2014 - 2022)

Company Filing History:

goldMedal11 out of 154 
 
Guardant Health, Inc.
 patents
silverMedal6 out of 1,227 
 
Illumina Corporation
 patents
bronzeMedal1 out of 1 
 
Guardant Helath, Inc.
 patent
4. 1 out of 5,519 
 
Leland Stanford Junior University
 patents

Years Active: 2014-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Analysis
Prenatal Diagnosis
Genetic Variants
Cell Free DNA
Rare Mutations
Copy Number Variation
Integrated Sequencing
Magnetic Separation
19 patents (USPTO):Explore Patents
1. 11519031 - Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA (2022-12-06),
2. 11519019 - Methods and systems for analyzing nucleic acid molecules (2022-12-06),
3. 10883139 - Methods and systems for detecting genetic variants (2021-01-05),
4. 10876171 - Systems and methods to detect rare mutations and copy number variation (2020-12-29),
5. 10870880 - Systems and methods to detect rare mutations and copy number variation (2020-12-22),
6. 10837063 - Systems and methods to detect rare mutations and copy number variation (2020-11-17),
7. 10781485 - Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA (2020-09-22),
8. 10457995 - Systems and methods to detect rare mutations and copy number variation (2019-10-29),
9. 10167505 - Integrated sequencing apparatuses and methods of use (2019-01-01),
10. 10041127 - Systems and methods to detect rare mutations and copy number variation (2018-08-07),
11. 9982295 - Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA (2018-05-29),
12. 9920366 - Methods and systems for detecting genetic variants (2018-03-20),
13. 9902992 - Systems and methods to detect rare mutations and copy number variation (2018-02-27),
14. 9840743 - Systems and methods to detect rare mutations and copy number variation (2017-12-12),
15. 9834822 - Systems and methods to detect rare mutations and copy number variation (2017-12-05),

Title: Innovator Profile - AmirAli Talasaz, Transforming Prenatal Diagnostics with Cutting-Edge Technologies

Introduction:

AmirAli Talasaz, a visionary inventor based in Menlo Park, CA, has made remarkable contributions in the field of prenatal diagnostics and nucleic acid analysis. With 19 patents to his name, Talasaz is at the forefront of non-invasive prenatal diagnosis, revolutionizing how genetic conditions in fetuses are detected.

Latest Patents:

Among his latest patents is the groundbreaking "Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA." This patent showcases Talasaz's innovative methods for determining fetal genetic information from a test sample containing a mixture of fetal cellular DNA and mother-and-fetus cfDNA. These methods are instrumental in identifying genetic diseases, analyzing copy number variations, and detecting genetic anomalies in unborn babies.

Additionally, Talasaz's patent on "Methods and systems for analyzing nucleic acid molecules" highlights his expertise in processing nucleic acid populations with varying forms and modifications. These methods enable comprehensive sequencing and analysis of multiple forms of nucleic acids, including RNA, DNA, and modified sequences, paving the way for integrated genetic and epigenetic insights.

Career Highlights:

Talasaz has made significant contributions during his tenure at companies like Guardant Health, Inc. and Illumina Corporation. His expertise and dedication have not only advanced the field of prenatal diagnostics but have also driven innovation in nucleic acid analysis technologies.

Collaborations:

Throughout his career, Talasaz has collaborated with esteemed professionals such as Helmy A Eltoukhy and Min-Jui Richard Shen. These collaborations have led to the development of cutting-edge technologies and solutions that have a profound impact on the field of genetic diagnostics.

Conclusion:

In conclusion, AmirAli Talasaz's relentless pursuit of innovation and his pioneering work in the field of prenatal diagnostics and nucleic acid analysis have earned him a well-deserved reputation as a visionary inventor. His patents and collaborations stand as a testament to his commitment to advancing healthcare through transformative technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…